Trial Profile
A study evaluating efficacy of 8 or 12 week treatment duration of ledipasvir/sofosbuvir for hepatitis C.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Oct 2017
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 23 Oct 2017 New trial record
- 08 Oct 2017 Results presented at the IDWeek 2017